International Journal of Biological and Medical Research (IJBMR) : eISSN 0976-6685
This statement outlines the ethical use, disclosure, and oversight of Generative AI (GenAI) in the submission, peer review, and editorial processes of this journal. It aligns with the principles and best practices established by leading organizations in academic publishing, including the Committee on Publication Ethics (COPE) https://publicationethics.org/.
Generative Artificial Intelligence (GenAI): Refers to artificial intelligence systems that generate text, images, code, audio, video, or other content based on patterns learned from training data. Examples include (but are not limited to) large language models (LLMs) such as ChatGPT, Gemini, Claude, and other AI-assisted writing tools.
AI-Assisted Writing Tools: Software applications that utilize GenAI to assist with drafting, editing, proofreading, or enhancing written content.
3.1. Ethical Use (COPE Guidelines)
All stakeholders, including authors, reviewers, and editors, must ensure that the use of AI tools adheres to COPE's Core Practices, including those relating to authorship, transparency, peer review, and data integrity. GenAI may assist in minor, mechanical tasks (e.g., grammar correction or summarization), but must not substitute for human intellectual contributions, nor be used to fabricate content or mislead readers.
3.2. Transparency
Authors are required to disclose the use of GenAI in their manuscripts. Disclosure must explicitly state which tools were used and for what purposes.
3.3. Authorship and Accountability
GenAI tools cannot be credited as authors, as they do not meet authorship criteria: substantial intellectual contribution, drafting or revising the work, and accountability for content. Authors remain fully responsible for the accuracy, originality, and ethical compliance of their submissions, even if AI tools were used.
3.4. Peer Review Integrity
Peer reviewers using GenAI tools must disclose such use to the editorial board; AI tools may provide suggestions or summaries but cannot replace the critical analysis or professional judgment required for peer review. Reviewers must not upload unpublished manuscripts to public AI tools, as this breaches confidentiality.
If GenAI tools are used in any phase of manuscript preparation, all authors must provide a clear disclosure statement regarding the use of GenAI. The statement should include the name(s) of the tool(s) used and the specific tasks where the tool was applied (e.g., language editing, visualization).
Example Disclosure Statement: "Generative AI tools, such as ChatGPT, were used for language editing and improving the clarity of the manuscript. All intellectual content, research design, and data analysis were conducted solely by the authors."
Authorship Remains Human: GenAI tools cannot be listed as authors or co-authors. Only human contributors who have made substantial intellectual contributions to the work qualify for authorship.
Accountability: The corresponding author and all listed authors bear full responsibility for the accuracy, originality, and integrity of the manuscript, including any content generated with AI assistance.
Human Authority: All editorial decisions (acceptance, revision, rejection) must be made by qualified editors and the editor-in-chief.
No GenAI for Decisions: Editors must not delegate decision-making authority to GenAI systems.
In alignment with COPE's misconduct policies, violations of this policy may result in: rejection of the manuscript; retraction of published articles if ethical breaches are discovered post-publication; notification to institutions, funders, or other stakeholders, where appropriate.
Related policies: Publication Ethics | Plagiarism | Journal Policies